Cyclo Therapeutics Inc (CYTH)
[[ item.lastPrice ]] [[ item.priceChange ]] ([[ item.percentChange ]]) [[ item.tradeTime ]] [NASDAQ]
[[ item.bidPrice ]] x [[ item.bidSize ]] [[ item.askPrice ]] x [[ item.askSize ]]
[[ session ]] by (Cboe BZX)
[[ item.lastPrice ]] [[ item.priceChange ]] ([[ item.percentChange ]]) [[ item.tradeTime ]] [NASDAQ]
[[ item.bidPrice ]] x [[ item.bidSize ]] [[ item.askPrice ]] x [[ item.askSize ]]
[[ session ]] [[ item.lastPriceExt ]] [[ item.priceChangeExt ]] ([[ item.percentChangeExt ]]) [[ item.tradeTimeExt ]]
Fiscal Year End Date: 12/31
(Values in U.S. thousands)
| 12-2023 | 12-2022 | 12-2021 | 12-2020 | 12-2019 | |
| Cash Flows From Operating Activities | |||||
| Net Income | -20,057 | -15,451 | -14,287 | -8,942 | -7,533 |
| Depreciation Amortization | 19 | 20 | 17 | 13 | 6 |
| Accounts receivable | -67 | 428 | -444 | 71 | -63 |
| Other Working Capital | 3,063 | -48 | -1,228 | 116 | 487 |
| Other Operating Activity | 857 | -63 | 937 | 201 | 513 |
| Operating Cash Flow | $-16,185 | $-15,114 | $-15,005 | $-8,540 | $-6,590 |
| Cash Flows From Investing Activities | |||||
| PPE Investments | -2 | -15 | -23 | -53 | -1 |
| Other Investing Activity | 0 | 53 | 37 | 39 | 37 |
| Investing Cash Flow | $-2 | $38 | $15 | $-14 | $36 |
| Cash Flows From Financing Activities | |||||
| Debt Issued | N/A | 15 | N/A | 159 | N/A |
| Debt Repayment | N/A | -8 | -7 | N/A | N/A |
| Common Stock Issued | 14,537 | N/A | 18,764 | 18,458 | 6,990 |
| Other Financing Activity | 9,354 | 0 | 0 | 0 | 130 |
| Financing Cash Flow | $23,891 | $7 | $18,757 | $18,617 | $7,120 |
| Beginning Cash Position | 1,543 | 16,613 | 12,846 | 2,784 | 2,217 |
| End Cash Position | 9,247 | 1,543 | 16,613 | 12,846 | 2,784 |
| Net Cash Flow | $7,703 | $-15,069 | $3,767 | $10,062 | $566 |
| Free Cash Flow | |||||
| Operating Cash Flow | -16,185 | -15,114 | -15,005 | -8,540 | -6,590 |
| Capital Expenditure | -2 | -15 | -23 | -53 | -1 |
| Free Cash Flow | -16,187 | -15,129 | -15,028 | -8,593 | -6,591 |